Skip to main content
. Author manuscript; available in PMC: 2016 Jun 22.
Published in final edited form as: J Adolesc Health. 2013 Sep 25;54(2):183–189. doi: 10.1016/j.jadohealth.2013.07.028

Figure 4.

Figure 4

Proportion of respondents who reported unaccompanied minors would not likely receive vaccine in Title X/family planning clinics within the context of hypothetical scenarios, by age and vaccine (n = 38).a,b aRespondents include Title X/family planning program managers and those who reported they were most familiar with practices in these clinic settings; for hypothetical scenarios, respondents were asked how likely it would be for cognitively normal adolescents of differing ages (e.g., 17, 15, 12 years) presenting for family planning services to be vaccinated in their state if the adolescent was medically eligible, the specific vaccine (e.g. influenza, Tdap, human papillomavirus [HPV], hepatitis [Hep] B) was available in the clinic at no cost, and a parent was not available even by phone for consent. bSignificant differences in likelihood of respondents reporting that 15- and 17-year-old unaccompanied minor would receive HPV versus Tdap, HPV versus influenza, Hep B versus Tdap, Hep B versus influenza (p < 001).